Legend Biotech (LEGN) Income towards Parent Company (2019 - 2025)

Legend Biotech (LEGN) has reported Income towards Parent Company for 7 consecutive years, with -$8.4 million the latest figure, recorded in Q4 2025.

• Income towards Parent Company for Q4 2025 came in at -$8.4 million, down 12000000100.0% year-over-year; the trailing twelve-month figure through Dec 2025 was -$171.1 million (down 27154444266.16% YoY), and the FY2025 annual result was -$268.4 million, down 55916666566.67% from the prior year.
• Income towards Parent Company was -$8.4 million for Q4 2025 at Legend Biotech, up from -$38.5 million in the prior quarter.
• Over five years, Income towards Parent Company peaked at $172.6 million in Q2 2021 and troughed at -$124.8 million in Q3 2021.
• Average Income towards Parent Company over 5 years is -$10.6 million, with a median of -$0.22 recorded in 2025.
• Year-over-year, Income towards Parent Company jumped 227.95% in 2021 and sank 33571891991.89% in 2025.
• Over 5 years, Income towards Parent Company stood at -$88.3 million in 2021, then surged by 100.0% to -$0.41 in 2022, then increased by 2.44% to -$0.4 in 2023, then surged by 117.5% to $0.07 in 2024, then slumped by 12000000100.0% to -$8.4 million in 2025.
• Per Business Quant data, the three most recent Income towards Parent Company figures were -$8.4 million in Q4 2025, -$38.5 million in Q3 2025, and -$124.2 million in Q2 2025.